These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 32098591)
1. Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations. Pereira M; Williams VL; Hallanger Johnson J; Valderrabano P Thyroid; 2020 Aug; 30(8):1132-1140. PubMed ID: 32098591 [No Abstract] [Full Text] [Related]
2. Changes in thyroid cancer incidence, post-2009 American Thyroid Association guidelines. Shi LL; DeSantis C; Jemal A; Chen AY Laryngoscope; 2017 Oct; 127(10):2437-2441. PubMed ID: 28092116 [TBL] [Abstract][Full Text] [Related]
3. Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Aschebrook-Kilfoy B; Grogan RH; Ward MH; Kaplan E; Devesa SS Thyroid; 2013 Aug; 23(8):1015-21. PubMed ID: 23360496 [TBL] [Abstract][Full Text] [Related]
4. Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea? Oh CM; Lim J; Jung YS; Kim Y; Jung KW; Hong S; Won YJ Cancer Med; 2021 Jun; 10(12):4087-4096. PubMed ID: 33979040 [TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939 [TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. Veiga LH; Neta G; Aschebrook-Kilfoy B; Ron E; Devesa SS Thyroid; 2013 Jun; 23(6):748-57. PubMed ID: 23410185 [TBL] [Abstract][Full Text] [Related]
8. Influence of Nomenclature Changes on Trends in Papillary Thyroid Cancer Incidence in the United States, 2000 to 2017. Kitahara CM; Sosa JA; Shiels MS J Clin Endocrinol Metab; 2020 Dec; 105(12):e4823-30. PubMed ID: 32984898 [TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011. O'Grady TJ; Gates MA; Boscoe FP Int J Cancer; 2015 Dec; 137(11):2664-73. PubMed ID: 26069163 [TBL] [Abstract][Full Text] [Related]
10. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker. Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747 [TBL] [Abstract][Full Text] [Related]
11. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Zhao L; Dias-Santagata D; Sadow PM; Faquin WC Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645 [TBL] [Abstract][Full Text] [Related]
12. Increasing incidence of thyroid cancer in the United States, 1973-2002. Davies L; Welch HG JAMA; 2006 May; 295(18):2164-7. PubMed ID: 16684987 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of the Follicular Variant of Papillary Thyroid Carcinoma From Classic Papillary Thyroid Carcinoma: An Ultrasound Analysis and Complement to Fine-Needle Aspiration Cytology. Ng SC; Kuo SF; Hua CC; Huang BY; Chiang KC; Chu YY; Hsueh C; Lin JD J Ultrasound Med; 2018 Mar; 37(3):667-674. PubMed ID: 28880405 [TBL] [Abstract][Full Text] [Related]
14. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma. Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595 [TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014. Weeks KS; Kahl AR; Lynch CF; Charlton ME Cancer; 2018 Apr; 124(7):1483-1491. PubMed ID: 29338082 [TBL] [Abstract][Full Text] [Related]
16. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. Du L; Wang Y; Sun X; Li H; Geng X; Ge M; Zhu Y BMC Cancer; 2018 Mar; 18(1):291. PubMed ID: 29544469 [TBL] [Abstract][Full Text] [Related]
17. The changing incidence of thyroid cancer. Kitahara CM; Sosa JA Nat Rev Endocrinol; 2016 Nov; 12(11):646-653. PubMed ID: 27418023 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg. Rendl G; Rodrigues M; Schweighofer-Zwink G; Hutter J; Hittmair A; Zellinger B; Hauser-Kronberger C; Pirich C Wien Klin Wochenschr; 2017 Aug; 129(15-16):540-544. PubMed ID: 28493027 [TBL] [Abstract][Full Text] [Related]
19. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346 [TBL] [Abstract][Full Text] [Related]